Robert E. Landry

Insider Reports History

Location
Tarrytown, NY
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Landry:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. EVP Finance CFO Common Stock 23,693 $22,665,908 $956.65 02 Feb 2024 Direct
CYTOKINETICS INC Director Common Stock 7,333 $273,667 $37.32 14 May 2025 Direct
REGENERON PHARMACEUTICALS, INC. EVP Finance CFO Common Stock 270 $252,372 $934.71 02 Feb 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. EVP Finance CFO Non-Qualified Stock Option (right to buy) 11,787 02 Feb 2024 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 11,500 12 Jan 2026 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 10,880 14 May 2025 Direct
Zymeworks Inc. Director Restricted Stock Unit 7,700 12 Jan 2026 Direct
Zymeworks Inc. Director No securities are beneficially owned 0 10 Aug 2025 Direct

Insider Reports Filed by Robert E. Landry

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 12 Jan 2026 2 $0 4 Director 12 Jan 2026, 20:56
ZYME Zymeworks Inc. 11 Aug 2025 1 $0 4 Director 12 Aug 2025, 20:30
ZYME Zymeworks Inc. 10 Aug 2025 0 $0 3 Director 12 Aug 2025, 20:00
CYTK CYTOKINETICS INC 14 May 2025 2 $0 4 Director 14 May 2025, 19:27
CYTK CYTOKINETICS INC 10 Feb 2025 1 $0 4 Director 11 Feb 2025, 08:26
CYTK CYTOKINETICS INC 10 Feb 2025 0 $0 3 Director 11 Feb 2025, 08:18
REGN REGENERON PHARMACEUTICALS, INC. 02 Feb 2024 3 -$117,227 4 EVP Finance CFO 06 Feb 2024, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 31 Jan 2024 3 -$117,272 4 EVP Finance CFO 02 Feb 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 23 Jan 2024 6 -$464,512 4 EVP Finance CFO 25 Jan 2024, 16:17
REGN REGENERON PHARMACEUTICALS, INC. 17 Jan 2024 3 -$140,558 4 EVP Finance CFO 18 Jan 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 12 Jan 2024 3 -$224,022 4 EVP Finance CFO 17 Jan 2024, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 04 Jan 2024 3 -$124,141 4 EVP Finance CFO 08 Jan 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2024 6 -$338,439 4 EVP Finance CFO 04 Jan 2024, 16:19
REGN REGENERON PHARMACEUTICALS, INC. 27 Dec 2023 6 -$407,916 4 EVP Finance CFO 29 Dec 2023, 16:05
REGN REGENERON PHARMACEUTICALS, INC. 12 Dec 2023 4 -$5,717,506 4 EVP Finance CFO 14 Dec 2023, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2023 3 -$3,573,573 4 EVP Finance CFO 12 Dec 2023, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 23 Aug 2023 1 -$188,212 4 EVP Finance CFO 25 Aug 2023, 17:02
REGN REGENERON PHARMACEUTICALS, INC. 27 Mar 2023 22 -$1,841,829 4 EVP Finance CFO 29 Mar 2023, 16:07
REGN REGENERON PHARMACEUTICALS, INC. 03 Feb 2023 18 -$1,753,048 4 EVP Finance CFO 07 Feb 2023, 15:09
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2022 2 $0 4 EVP Finance CFO 20 Dec 2022, 15:07
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2022 4 -$962,523 4 EVP Finance CFO 12 Dec 2022, 15:34
REGN REGENERON PHARMACEUTICALS, INC. 01 Dec 2022 6 -$943,825 4 EVP Finance CFO 02 Dec 2022, 15:05
REGN REGENERON PHARMACEUTICALS, INC. 31 Oct 2022 13 -$741,929 4 EVP Finance CFO 02 Nov 2022, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 14 Oct 2022 4 -$541,258 4 EVP Finance CFO 18 Oct 2022, 16:06
REGN REGENERON PHARMACEUTICALS, INC. 07 Apr 2022 28 -$3,276,534 4 EVP Finance CFO 11 Apr 2022, 18:01
REGN REGENERON PHARMACEUTICALS, INC. 31 Mar 2022 5 -$450,357 4 EVP Finance CFO 01 Apr 2022, 16:07
REGN REGENERON PHARMACEUTICALS, INC. 28 Mar 2022 29 -$3,758,253 4 EVP Finance CFO 30 Mar 2022, 16:42
REGN REGENERON PHARMACEUTICALS, INC. 21 Mar 2022 4 -$270,821 4 EVP Finance CFO 23 Mar 2022, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 16 Mar 2022 5 -$315,832 4 EVP Finance CFO 18 Mar 2022, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 10 Dec 2021 5 -$625,837 4 EVP Finance CFO 14 Dec 2021, 15:03
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2021 21 -$1,101,437 4 EVP Finance CFO 10 Dec 2021, 16:37
REGN REGENERON PHARMACEUTICALS, INC. 16 Nov 2021 4 -$941,470 4 EVP Finance CFO 18 Nov 2021, 15:23
REGN REGENERON PHARMACEUTICALS, INC. 31 Aug 2021 3 -$63,333 4 EVP Finance CFO 01 Sep 2021, 16:05
REGN REGENERON PHARMACEUTICALS, INC. 06 Aug 2021 22 -$1,159,116 4 EVP Finance CFO 10 Aug 2021, 17:55